Investigating the Pretreatment miRNA Expression Patterns of Advanced Hepatocellular Carcinoma Patients in Association with Response to TACE Treatment

Table 1

Baseline laboratory values in 15 patients with advanced HCC treated with TACE.

Parameter	Mean ± SD	Median (IQR)
Total bilirubin (mg/dL)	1.2 ± 0.6	0.9 (0.7–1.7)
Albumin (mg/dL)	3.1 ± 0.6	3.1 (2.675–3.575)
AST (U/mL)	53.1 ± 27.5	51.5 (32.8–69.3)
ALT (U/mL)	46.1 ± 22.4	46.0 (30.3–61.0)
INR	1.2 ± 0.3	1.2 (1–1.3)
Creatinine (mg/dL)	0.8 ± 0.2	0.8 (0.7–0.9)
Hemoglobin (g/dL)	13.3 ± 1.9	13.5 (12.5–14.8)
WBC (1000/mL)	6.3 ± 1.3	6.1 (5.4–7.3)
Platelets (1000/mL)	174.2 ± 56.2	172 (132–199)

SD: standard deviation, IQR: interquartile range, AST: aspartate transaminase, ALT: alanine transaminase, INR: international normalized ratio, AFP: alpha-fetoprotein, and WBC: white blood cells.